Efficacy of Ustekinumab combined with partial enteral nutrition in Crohn’s disease

BackgroundUstekinumab (UST) has emerged as an effective biological therapy for Crohn’s disease (CD), yet many patients experience suboptimal long-term mucosal healing. Partial enteral nutrition (PEN) may enhance treatment outcomes by reducing intestinal inflammation and improving nutritional status....

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Hanyu Yin, Chao Chen, Xiaowei Chen, Weixiang Yao, Chen Huang, Jiahe Chen, Mengying Zhu, Xiaoli Wu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-05-01
Sarja:	Frontiers in Nutrition
Aiheet:	clinical remission Crohn’s disease endoscopic remission partial enteral nutrition Ustekinumab
Linkit:	https://www.frontiersin.org/articles/10.3389/fnut.2026.1825135/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!